Halozyme signs mammoth drug partnerships

Favicon UT San Diego

Halozyme Therapeutics will get $135 million cash upfront and potential milestone payments of up to $1.92 billion under two partnerships announced Thursday. The deals greatly expands the use of the San Diego biotech’s drug delivery technology, which enables drugs to be absorbed under the skin, or...

Read the full article here: UT San Diego


The post: «Halozyme signs mammoth drug partnerships» has been published on the website UT San Diego where, everyday, you can find the latest news about San Diego's area.



Get more articles about this topic

Leave a comment